Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

The current management landscape: aspergillosis: Table 1.

(2016) Johan A. Maertens et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies

(2015) Issam I. Raad et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Serum galactomannan levels in the diagnosis of invasive aspergillosis

(2015) Yildiz Okuturlar et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

(2015) Monica Fung et al.   PLoS One

Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group

(2014) Raoul Herbrecht et al.   CLINICAL INFECTIOUS DISEASES

Update on antifungal resistance in Aspergillus and Candida

(2013) M.C. Arendrup   CLINICAL MICROBIOLOGY AND INFECTION

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

(2013) C Orla Morrissey et al.   LANCET INFECTIOUS DISEASES

The role of antifungal treatment in hematology

(2012) J. A. Maertens et al.   HAEMATOLOGICA

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

(2012) J. D'Haese et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009

(2011) M.-C. Nicolle et al.   HAEMATOLOGICA

Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach

(2011) M. Aguilar-Guisado et al.   HAEMATOLOGICA

Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study

(2011) Ban Hock Tan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles

(2011) E. R. Ramos et al.   ONCOLOGIST

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

(2009) F L Dignan et al.   BONE MARROW TRANSPLANTATION

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

(2009) Catherine Cordonnier et al.   CLINICAL INFECTIOUS DISEASES

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

(2009) Corrado Girmenia et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES